Evidence map›Paper›PMID 35239108›Full record

ArticleMedical & biological engineering & computing2022

A real use case of semi-supervised learning for mammogram classification in a local clinic of Costa Rica.

Saul Calderon-Ramirez, Diego Murillo-Hernandez, Kevin Rojas-Salazar, David Elizondo, Shengxiang Yang, Armaghan Moemeni, Miguel Molina-Cabello

Abstract read
In one paragraph

Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saul Calderon-RamirezCentre for Computational Intelligence (CCI), De Montfort University, Leicester, UK. sacalderon@itcr.ac.cr.ORCID http://orcid.org/0000-0001-9993-4388
Diego Murillo-HernandezPARMA Research Group, Instituto Tecnológico de Costa Rica, Cartago, Costa Rica.
Kevin Rojas-SalazarPARMA Research Group, Instituto Tecnológico de Costa Rica, Cartago, Costa Rica.
David ElizondoCentre for Computational Intelligence (CCI), De Montfort University, Leicester, UK.
Shengxiang YangCentre for Computational Intelligence (CCI), De Montfort University, Leicester, UK.
Armaghan MoemeniSchool of Computer Science, University of Nottingham, Nottingham, UK.
Miguel Molina-CabelloDepartment of Computer Languages and Computer Science, University of Málaga, Málaga, Spain.

Funding

ministerio de ciencia, innovación y universidades RTI2018-094645-B
6 · The paper itself

Abstract

The implementation of deep learning-based computer-aided diagnosis systems for the classification of mammogram images can help in improving the accuracy, reliability, and cost of diagnosing patients. However, training a deep learning model requires a considerable amount of labelled images, which can be expensive to obtain as time and effort from clinical practitioners are required. To address this, a number of publicly available datasets have been built with data from different hospitals and clinics, which can be used to pre-train the model. However, using models trained on these datasets for later transfer learning and model fine-tuning with images sampled from a different hospital or clinic might result in lower performance. This is due to the distribution mismatch of the datasets, which include different patient populations and image acquisition protocols. In this work, a real-world scenario is evaluated where a novel target dataset sampled from a private Costa Rican clinic is used, with few labels and heavily imbalanced data. The use of two popular and publicly available datasets (INbreast and CBIS-DDSM) as source data, to train and test the models on the novel target dataset, is evaluated. A common approach to further improve the model's performance under such small labelled target dataset setting is data augmentation. However, often cheaper unlabelled data is available from the target clinic. Therefore, semi-supervised deep learning, which leverages both labelled and unlabelled data, can be used in such conditions. In this work, we evaluate the semi-supervised deep learning approach known as MixMatch, to take advantage of unlabelled data from the target dataset, for whole mammogram image classification. We compare the usage of semi-supervised learning on its own, and combined with transfer learning (from a source mammogram dataset) with data augmentation, as also against regular supervised learning with transfer learning and data augmentation from source datasets. It is shown that the use of a semi-supervised deep learning combined with transfer learning and data augmentation can provide a meaningful advantage when using scarce labelled observations. Also, we found a strong influence of the source dataset, which suggests a more data-centric approach needed to tackle the challenge of scarcely labelled data. We used several different metrics to assess the performance gain of using semi-supervised learning, when dealing with very imbalanced test datasets (such as the G-mean and the F2-score), as mammogram datasets are often very imbalanced. Graphical Abstract Description of the test-bed implemented in this work. Two different source data distributions were used to fine-tune the different models tested in this work. The target dataset is the in-house CR-Chavarria-2020 dataset.

Indexed as

Diagnosis, Computer-AssistedSupervised Machine LearningCosta RicaHumansMammographyReproducibility of ResultsBreast cancerData imbalanceMammogramSemi-supervised deep learningTransfer learning

Identifiers

PMID35239108
PMCPMC8892413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.